Close menu

January 10th, 2022 | 11:14 CET

Alibaba, Hong Lai Huat, Xiaomi - Asian stocks catching up?

  • Investments
Photo credits:

The year 2021 was often a year to forget for investors in the Asian region. Chinese stocks, in particular, suffered from government regulation, causing many stocks to plummet despite good numbers. After the dip in 2020 due to the Corona pandemic, the economy made significant gains, but this rapid growth will not continue so quickly in 2022. Nevertheless, the first investors are sensing a trend reversal due to the discrepancy in stock market developments. While the US stock market climbed strongly in 2021, the Hang Seng fell 13% plus. There has not been such a difference since the Asian crisis. We take a look at three interesting shares from the Asian region.

time to read: 4 minutes | Author: Armin Schulz

Table of contents:

    Alibaba - Are the investments paying off?

    Alibaba shareholders have had to swallow a few toads in recent months. It started with the cancellation of Ant Financial's IPO because the Chinese government objected. On top of that, there was a USD 2.8 billion fine for antitrust violations. The government pressured State-owned Chinese companies to switch to state-owned cloud providers and some other regulatory actions. Despite all the opposition, the Company managed to bring the cloud division into profit for the first time in 2021. All other business units are also growing, albeit at a slower pace.

    Even though the last quarterly figures disappointed investors, this was mainly due to the investments made in future topics. Financially, Alibaba is very well positioned and is debt-free if you look at its liabilities and cash on hand. According to experts, one weak point was the lack of social media networking. In response, they launched DingTalk and have already won over 500 million users. The Company also wants to leave its mark in the new hype of the Metaverse. To this end, around USD 1.6 million was invested in the Company Yuanjing Shengsheng.

    We see the fear of a delisting as unfounded, as such a step would have a devastating consequence for the Chinese economy because then investments in China would be very risky. The government cannot want that. If you look at the analyst valuations, the average price target is USD 203. Also, Charlie Munger, through a company, almost doubled his shares again in the last quarter of 2021. When comparing the Company to its peers, Alibaba's price-to-earnings ratio is by far the best. The stock is trading at USD 129.81 and has recently formed a double bottom at around USD 110.

    Hong Lai Huat - Mega project in Cambodia

    Hong Lai Huat Group was founded in 1998 and is headquartered in Singapore. The Company is a real estate developer and builder and has expanded its businesses over the years. Agriculture and land development has been part of its portfolio since 2008. Since 2021, the Company has also been active in land development and the leasing of completed properties. The Group also has a diversified geographical footprint with Singapore and Cambodia.

    In Singapore, eight notable residential, commercial and industrial buildings have been constructed and developed. Currently, the Company has three ongoing projects in Cambodia. First, the 100% company-owned D'Seaview project is already fully completed and consists of 737 residential and 67 commercial units. 85% of all units have already been sold at USD 1,300 per sqm. Secondly, there is a 50% stake in the Royal Platinum project, which is expected to be completed by year-end 2023. The development consists of 851 residential and 50 commercial units sold at USD 2,000 per sqm. To date, only 20% have been sold, largely due to Corona restrictions.

    The Company landed the mammoth Agri Hub project on June 17, 2021, when Cambodian authorities gave the go-ahead to convert 100 million sqm or 100 sq km of agricultural land into mixed construction land. The area is 130m above sea level and a 60-minute drive from the capital Phnom Penh, making it safe from tsunamis. The development will include factories, logistics centers, renewable energy, plantations, livestock, water treatment, housing and more. The value of the current projects is currently likely to be three times the market capitalization at a current share price of EUR 0.068. Those who want to take a closer look can watch the company presentation on February 17 at the International Investment Forum.

    Xiaomi - Looking to diversify

    Xiaomi managed to displace Apple to third place in smartphone sales in 2021 and is now chasing industry leader Samsung. But if you think it has been a good year for investors in the Company, you are wrong. Due to the US and China trade war, the Company was blacklisted in America from January until the end of May 2021. Add to that the regulatory fury from Beijing and a weak Hong Kong market considered one of the Company's main markets.

    What is next for 2022? The results for the first nine months of 2021 show a very positive trend across the board. Sales were 242 billion Chinese yuan (CNY), or the equivalent of around EUR 33.5 billion, up 38.4% YOY. Gross profit climbed 71.5% to CNY 43.6 billion. But margins in the smartphone industry are small, so the Company is trying to diversify further by entering other businesses such as electric vehicles (EV) and semiconductor chips. They also invested more money in the development of vacuum cleaners. The Company has long been a big player in the electric consumer goods sector.

    There are rumors about acquiring the EV division of the struggling real estate developer Evergrande. But so far, there has been no confirmation on that. Morningstar analysts have recently raised the price target for the share to the equivalent of EUR 2.71 upwards. Currently, the share is trading at EUR 2.06 and is in a clear downward trend. A closing price above EUR 2.14 on a closing price basis would be the first bullish signal. To break the downward trend, prices above EUR 2.40 are necessary.

    Many Asian stocks have fallen under the radar in the past year. Uncertainty is not something any investor likes, but the bad news should have been priced in by now. The discounts compared to the competition are enormous, so there is considerable catch-up potential in some cases. Alibaba, unlike many US tech companies, has already jumped this year and made gains. Hong Lai Huat landed a big deal that will keep the Company busy for a few years. Xiaomi is trying to position itself even more broadly to achieve a turnaround this year. The next figures will be exciting.

    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.

    Der Autor

    Armin Schulz

    Born in Mönchengladbach, he studied business administration in the Netherlands. In the course of his studies he came into contact with the stock exchange for the first time. He has more than 25 years of experience in stock market business.

    About the author

    Related comments:

    Commented by Juliane Zielonka on September 29th, 2023 | 07:00 CEST

    Defence Therapeutics, Schott Pharma, Allianz Group: Focus on Innovation, Growth and Portfolio Optimization

    • Biotechnology
    • Pharma
    • Investments

    According to a recent study, biotech company Defence Therapeutics achieves twice the immune response of conventional mRNA therapies with its Accum® mRNA technology. That translates to fewer side effects and a more effective treatment. According to Precedence Research, the market size for mRNA therapeutics is projected to reach approximately USD 137.59 billion by 2032. It is expected to grow at a CAGR of 13.2% from 2023 to 2032. In order to inject these active ingredients, precision-fit medical vials are required, and Schott Pharma is ensuring this with their IPO launched on the German stock exchange this week, which could bring a valuation of around EUR 4 billion. The Allianz Group, on the other hand, is focusing on consolidation, selling its business in the Middle East and thus flushing around EUR 210 million cash into its coffers.


    Commented by André Will-Laudien on September 26th, 2023 | 07:45 CEST

    Artificial Intelligence in Sellout! Nvidia, Defense Metals, ARM Holdings - Nothing works without rare earths!

    • Mining
    • RareEarths
    • AI
    • chips
    • Investments

    After long bull market movements, the stock market usually tends to rotate sectors, or the market enters a general consolidation. In the former case, investors can profit by reallocating their assets while exploring new investment opportunities. In the latter case, all stocks come down, and the capital market generally suffers from a change in sentiment and corrects recently exaggerated valuations. In the case of the new megatrend of Artificial Intelligence (AI), the stock market seems to sense a great need for correction. As if by magic, the blockbuster stock Nvidia rose by 250% in just 9 months. However, it has already retraced nearly 20% from its peak. Where do the opportunities lie for investors?


    Commented by André Will-Laudien on September 22nd, 2023 | 07:20 CEST

    Recalculation! These are the bare figures: TUI, Saturn Oil + Gas, Deutsche Bank - Buy prices non-stop!

    • Mining
    • Oil
    • travel
    • Investments
    • Banking

    Companies do not always have good figures in their baggage. Analysts listen very carefully to the words of those in charge. Often, it is only a minor sentence that changes entire valuations. TUI is slowly approaching pre-COVID figures. Saturn Oil & Gas must backtrack slightly because of substantial forest fires in Alberta, and Deutsche Bank aims to finalize the Postbank project in 2023. All three stocks offer good buying opportunities because the long-term prospects are quite convincing.